More serious side effects can also include chest pain, bleeding gums, eye pain, irregular heartbeat, swelling around the face and extremities, and hives
Injectable GHK-Cu delivers copper directly into tissue, potentially contributing to total body copper load
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine, originally isolated by Loren Pickart from human plasma in 1973. The compound is one of the most extensively characterized small peptides in published research, with documented effects on collagen synthesis, glycosaminoglycan production, and approximately 4,000 human gene expression changes
Product has been consistent and easy to work with
GHK-Cu is one of the most stack-friendly compounds because its mechanism does not compete with other common research compounds